Lepercq De Neuflize Asset Management LLC Enzo Biochem Inc Transaction History
Lepercq De Neuflize Asset Management LLC
- $103 Billion
- Q1 2025
A detailed history of Lepercq De Neuflize Asset Management LLC transactions in Enzo Biochem Inc stock. As of the latest transaction made, Lepercq De Neuflize Asset Management LLC holds 156,303 shares of ENZ stock, worth $85,966. This represents 0.06% of its overall portfolio holdings.
Number of Shares
156,303
Previous 123,000
27.08%
Holding current value
$85,966
Previous $87.9 Million
34.18%
% of portfolio
0.06%
Previous 0.06%
Shares
2 transactions
Others Institutions Holding ENZ
# of Institutions
46Shares Held
16.4MCall Options Held
0Put Options Held
0-
Harbert Fund Advisors, Inc. Birmingham, AL5.18MShares$2.85 Million2.17% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny2.08MShares$1.15 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.86MShares$1.02 Million0.0% of portfolio
-
Potomac Capital Management, Inc.1.48MShares$814,9583.63% of portfolio
-
Viex Capital Advisors, LLC Sunny Isles Beach, FL1.33MShares$733,9639.62% of portfolio
About ENZO BIOCHEM INC
- Ticker ENZ
- Exchange NYSE
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 48,720,500
- Market Cap $26.8M
- Description
- Enzo Biochem, Inc., an integrated diagnostics, clinical lab, and life sciences company, researches, develops, manufactures, and markets diagnostic and research products based on genetic engineering, biotechnology, and molecular biology. It operates through three segments: Life Sciences Products, Clinical Laboratory Services, and Therapeutics. Th...